fbpx

Lung Cancer

Carcinoma of Upper Lobe of Right Lung

Male, 62 years

Patient Internal ID: 102389711

ICD-10 code

C34.1 Malignant Neoplasm of Upper Lobe, Bronchus or Lung

Diagnosis (Incl. Metastases/Stage) and Year

December 2010
Carcinoma of Upper Lobe of Right Lung pT1a N0M0R0 G2 I st.
May 2020 disease progression.
Pleomorphic Carcinoma of the Lung with Partial  Neuroendocrine Differentiation with Metastasis in both Lungs pT1aNxM1.

Previous Treatment

Surgery (Segmentectomy), Target Therapy (Erlotinib), Radiation Therapy, Surgery (Segmentectomy – 2nd), Chemotherapy (Carboplatin, Paclitaxel), Chemotherapy (Gemcitabine).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~1 year from diagnosis.

Treatment Provided

Autologous DCV (10 doses) and CIK (4 doses) over a period of 14 months. Additionally, the patient received Umbilical Cord Blood Derived NK cells (8 doses).

Patient Survival/Condition and Year
Date of Review: 15/10/2023

After the disease progression, the patient survived for 3 years. It can be concluded that Immunotherapy, alongside Surgery, Chemotherapies and Radiation Therapy, has extended the patient’s survival by around 2 years compared with median survival.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.